Shiba Pharma Honored as One of Yemen’s Most Prominent Companies for 2025
The Investor Foundation for Economic Journalism honored Shiba Pharma as one of the most prominent companies in Yemen for 2025, in recognition of its excellence in producing pharmaceuticals that meet international standards and its commitment to providing safe, high-quality, and affordable products.
Dr. Ihsan Al-Rabahi, Chairman of the Board, received the award and emphasized that this achievement serves as a strong motivation to further advance the pharmaceutical industry and introduce new innovations that enhance drug security in Yemen.
The Executive Director of the Investor Foundation praised Shiba Pharma’s pioneering role, noting its consistent commitment to the highest standards of quality in pharmaceutical production and its contribution to serving the community.
It is worth noting that Shiba Pharma has obtained international quality certifications and continues to provide reliable medicines at affordable prices, making it one of the leading pharmaceutical companies in Yemen.
#ShibaPharma #Yemen #PharmaceuticalIndustry #DrugSecurity #QualityStandards #Award #YemeniPharmaCompany
Source:
Alestethmar.net
Investment Award 2024
